Investigational drug · Phase 2
AST-201
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Advanced Ovarian Cancer.
Phase 2Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "AST-201"
First trial start
2027
Jun 1, 2027
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "AST-201", any sponsor or status.
Conditions studied
As listed on its trial records.
- Advanced Ovarian Cancer
Approved drugs for the same conditions: Ovarian cancer · Oncology
Largest trials
Live from ClinicalTrials.gov: studies naming "AST-201" as an intervention, largest first.
- Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian CancerNot yet recruiting
Aston Sci. Inc.Industry
NCT05794659 · 98 participants (planned) · Start Jun 1, 2027 · Primary completion Dec 31, 2030
Drug: AST-201; Paclitaxel and 3 more · For: Advanced Ovarian Cancer
Sites: Seattle, Washington
Aptamer Sciences, Inc.Industry
NCT06687941 · 70 participants (planned) · Start Mar 11, 2025 · Primary completion Dec 2027
Drug: AST-201 · For: Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung and 1 more
Sites: Goyang-si, South Korea; Seongnam, South Korea; Seoul, South Korea · 4 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Advanced Ovarian Cancer
- rhuGM-CSFGranulocyte-Macrophage Colony-Stimulating FactorPhase 22 trials
Aston Sci. Inc. · Gastric Cancer, Advanced Ovarian Cancer
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.